Cetera Investment Advisers Abbott Laboratories Transaction History

Cetera Investment Advisers

$42.2 Billion
Q2 2024

A detailed history of Cetera Investment Advisers transactions in Abbott Laboratories stock. As of the latest transaction made, Cetera Investment Advisers holds 414,828 shares of ABT stock, worth $47.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

414,828

Previous 470,298 11.79%

Holding current value

$47.3 Million

Previous $53.5 Million 19.36%

% of portfolio

0.1%

Previous 0.13%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 22, 2024	SELL	$100.73 - $112.44 $5.59 Million - $6.24 Million	-55,470 Reduced 11.79%	414,828 $43.1 Million
Q1 2024 May 24, 2024	BUY	$109.52 - $120.96 $39.6 Million - $43.7 Million	361,132 Added 330.81%	470,298 $53.5 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $1.84 Million - $2.04 Million	-16,826 Reduced 13.35%	109,166 $12.4 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $262,272 - $321,043	-2,908 Reduced 2.26%	125,992 $13.9 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $301,970 - $362,313	3,161 Added 2.51%	128,900 $12.5 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $367,443 - $409,409	-3,646 Reduced 2.82%	125,739 $13.7 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $837,645 - $985,958	-8,648 Reduced 6.27%	129,385 $13.1 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $42.4 Million - $49.7 Million	-445,931 Reduced 76.36%	138,033 $15.2 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $26.7 Million - $30.9 Million	276,106 Added 89.69%	583,964 $57,000
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $48,789 - $58,970	-478 Reduced 0.16%	307,858 $33.4 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $321,422 - $391,953	2,819 Added 0.92%	308,336 $36.5 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $186,118 - $227,892	1,611 Added 0.53%	305,517 $43 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $70,695 - $78,210	606 Added 0.2%	303,906 $35.9 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $698,425 - $822,147	6,602 Added 2.23%	303,300 $35.2 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $21.1 Million - $24.8 Million	193,414 Added 187.26%	296,698 $35.6 Million
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $8.76 Million - $9.55 Million	83,425 Added 420.09%	103,284 $11.3 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $17,319 - $21,033	189 Added 0.96%	19,859 $2.16 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $117,381 - $150,234	-1,533 Reduced 7.23%	19,670 $1.8 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $67,782 - $99,116	1,079 Added 5.36%	21,203 $1.67 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $16,330 - $18,179	208 Added 1.04%	20,124 $1.75 Million
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $63,262 - $68,596	-773 Reduced 3.74%	19,916 $1.66 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $133,661 - $155,890	1,834 Added 9.73%	20,689 $1.73 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $45,360 - $54,841	-685 Reduced 3.51%	18,855 $1.5 Million
Q4 2018 Feb 15, 2019	BUY	$65.56 - $74.27 $524 - $594	8 Added 0.04%	19,540 $1.41 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $133,599 - $161,171	2,197 Added 12.67%	19,532 $1.43 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $100,171 - $110,559	-1,740 Reduced 9.12%	17,335 $1.06 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $78,778 - $89,068	1,400 Added 7.92%	19,075 $1.14 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $91,578 - $98,043	1,706 Added 10.68%	17,675 $1.01 Million
Q3 2017 Nov 16, 2017	BUY	$48.06 - $53.64 $38,063 - $42,482	792 Added 5.22%	15,969 $851,000
Q2 2017 Aug 17, 2017	SELL	N/A	-12,438 Reduced 45.04%	15,177 $740,000
Q2 2017 Aug 14, 2017	BUY	N/A	27,615	27,615 $1.34 Million

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Abbott Laboratories Transaction History